Michael Casey, MD
Nephrology · Charleston, SCNPI 1194991026
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $3,987 of the $4,783 with a category attached, or 83.3%. Medtronic accounts for 87.9% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2019 at $4,207 and has fallen 95.0% since, to $209 in 2025.
Across 27 payments — averaging $177.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$4K
- Amgen$174
- Stryker$168
- Veloxis Pharmaceuticals, Inc.$120
- Mallinckrodt Hospital Products Inc.$49
- Apellis Pharmaceuticals, Inc.$35
- plus $31 from 1 others
What the payments were for
- Travel & lodging$3,98783%
- Food & beverage$79617%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 10 | $4,207 |
| Amgen | 9 | $174 |
| Stryker | 1 | $168 |
| Veloxis Pharmaceuticals, Inc. | 1 | $120 |
| Mallinckrodt Hospital Products Inc. | 2 | $49 |
| Apellis Pharmaceuticals, Inc. | 2 | $35 |
| AstraZeneca | 2 | $31 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,783 in reported general payments places this provider in the 75th percentile of 180 nephrology providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Envarsus XrTacrolimus | 29 | $36,451 |
| NulojixBelatacept | 13 | $26,091 |
| Cinacalcet Hcl | 57 | $14,843 |
| Atovaquone | 23 | $10,794 |
| Valganciclovir Hcl | 11 | $4,266 |
| Tacrolimus | 21 | $2,890 |
| Prednisone | 401 | $2,566 |
| Amlodipine Besylate | 224 | $1,774 |
| Nifedipine ErNifedipine | 56 | $1,731 |
| Carvedilol | 148 | $1,316 |
| Mycophenolate Mofetil | 21 | $1,199 |
| Calcitriol | 22 | $637 |
| Labetalol Hcl | 13 | $502 |
| Hydralazine Hcl | 26 | $450 |
| Potassium Chloride | 21 | $443 |
Paid to pharmacies, not to this prescriber.
Other nephrology in Charleston
- Harold SzerlipCharleston$229K
- Joshua LipschutzCharleston$44K
- Charles BunkeCharleston$39K
- Anand AchantiCharleston$38K
- Blaithin McMahonCharleston$11K
- Michael MadaioCharleston$10K
- Roberto PisoniCharleston$7K
- Rohan KatariaCharleston$4K
- Jessica ColemanBeaufort$930K
- Moustafa MoustafaOrangeburg$616K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.